The size of the home healthcare market in Europe is estimated to value USD 159.16 billion by 2029 from USD 105.07 billion in 2024, growing at a CAGR of 8.66% during the forecast period.
An increase in older people is anticipated to reach 130.2 million by 2050. European government had issued a wide range of reimbursement policies to the patients. Outpatient care expenditures in Europe are covered under mandatory financing schemes the government serves, driving the market growth of home healthcare. In many cases, most European countries cover outpatient specialists and primary carefree of cost. All these reimbursement policies assured by the European government are expected to boost the European home healthcare market growth.
The major market players merging with organizations to provide home healthcare services are boosting the growth of the European home healthcare market. The rising acquisitions between organizations is significant market strategy organizations follow to increase market growth. The increasing demand for home caretakers after surgeries or for chronic patients from family members due to their busy lifestyles is accelerating market growth.
Medtronic's Integrated Healthcare System (HIS) has 170 long-term partnerships in 24 countries across the European region. It assures value to healthcare organizations by supporting the delivery of high-quality service at home care with cost-effectiveness. People with growing busy lifestyles are adopting the market trend of home healthcare for patients at home.
The mentality of the nurses towards the patients is expected to be harsh as the patients are estimated to lose their freedom of movement. This scares most patients to take home healthcare facilities, hampering the European home healthcare market growth. Most of the cases claimed that nurses locked the patients in different rooms regularly, which impacted the patients and limited market growth. Limited insurance coverage for home healthcare services is restraining the market growth. The standard regulations for approving government home healthcare services are challenging because government processes take time and effort. The private healthcare providers are expensive, which is expected to hinder the market growth. Home healthcare services do not have any standard regulations or rules, and this lack of standardization impedes the regional market growth.
The therapeutic products segment held the largest European home healthcare market revenue share in 2023. The rising incidence of chronic ailments such as respiratory disorders, kidney diseases, and others increased the demand for therapeutic equipment at home healthcare. Therapeutic equipment for diagnosing, preventing, treating, or modifying any physiological process enhances market growth.
The home telehealth software segment acquired a significant market revenue share in 2023 as the software acts as a control portal. Home telehealth supports live patient interaction through video, audio, and messaging. The software segment controls these live interactions with the patient, which has greatly impacted the market growth.
Skilled nursing care services will dominate the market share in 2023. Most patient conditions demand skilled nurses as regular medications are necessary, which induced market growth in the skilled nursing care services segment. Skilled nurses are helpful in all other ways, as nurses can handle emergencies.
The hospice solutions segment held the largest share of the European market revenue in 2023 as they provide emotional, physical, and social support. This segment is expected to dominate the market over the forecast period due to its functionalities, making it easy to manage the clinic. This system includes appointments, doctor schedules, prescriptions, and others.
Germany dominated the European Home healthcare market and is anticipated to grow with the highest CAGR over the forecast period. This is due to rapid urbanization, causing the growth of older adults nationwide. European countries like the UK, Germany, and France have advanced healthcare infrastructure and high disposable incomes, accelerating market growth. The increasing government initiatives to decrease the healthcare system cost enhance the home healthcare market value in Spain and Italy. The increasing prevalence of chronic diseases and older adults is driving the market expansion in the European region. The rising collaborations and acquisitions between organizations and healthcare organizations are fuelling the home healthcare market in these countries.
Notable companies dominating in the European Home Healthcare Market profiled in the report are Almost Family Inc., Amedisys Inc., General Electric Company (GE), Kinnser Software Inc., Linde Group, Omron Corporation, Roche Holding AG, Philips Healthcare, Mckesson Corporation, LHC Group Inc., Kindred Healthcare, Fresenius Se & Co Kgaa, Abbott Laboratories, and Apria Healthcare Group.
Frequently Asked Questions
Spain and Italy are among the key contributors to the home healthcare market in Southern Europe, accounting for a substantial market share.
The growing aging population, increasing prevalence of chronic diseases and a rising preference for in-home care are key factors driving the home healthcare market in Europe.
The COVID-19 pandemic has accelerated the adoption of home healthcare services in Europe.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region